Start A Thread

Rate Johnson & Johnson

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment



In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position


* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.


Hot Ticker Articles

Johnson & Johnson Medical Device Business Underperforms in Q3

Auris Health Announces Results from Study of Monarch Platform at CHEST 2018

The Medtechy Daily: October 15

Zimmer Biomet and Apple Launch Clinical Study for Patients Getting Knee and Hip Replacements

Corindus Vascular Robotics Publishes New Videos from TCT 2018

Cleveland Clinic First in the U.S. to Perform Prostate Surgery Using Intuitive Surgical's Single Port SP Robot

TransEnterix 2018 Key Priorities Still on Track

Spinal Cord Stimulator Helps Paralyzed Patients Walk Again

Free Job Postings on Medtechy Jobs Until 2019

Apps for New Apple Watch Get FDA Clearance - What Does it Mean

Johnson & Johnson Message Board

Johnson & Johnson, Ethicon, DePuy Synthes, Acclarent, Mentor, Biosense Webster, Advanced Sterilization Products employees

4 days ago

Huge chunk of DePuy Synthes was divested to Jabil. Now JNJ will eliminate or reduce the DePuy Synthes product codes made at these Jabil facilities, and Jabil will eliminate thousands of jobs.

JNJ Please Sell MD&D

4 days ago

Mr. Gorsky, please selloff MDD. If you poled MDD employees, you would realize that most all of us feel like red-headed step children. We get it, Pharma makes more money and you love consumer. Wouldn't selling MDD off let you focus on the children you actually love?

Sales decreased .2% YOY last quarter. Does that make you happy? It doesn't make us happy but we need better parents who love us. Do the right thing, Mr. Gorsky and put us up for adoption or split us off and let us spread our wings.

JNJ Robotic Surgery Program

6 days ago

Worst case scenario, they never launch a robot or something that is substantial to JNJ's revenue. I would argue this is the more likely scenario.

JnJ Executive Committee Changes

1 week ago

No doubt the MDD sector has been a clown show. Could not agree more on the acquisition failures. Synthes has been a total disaster! The global device sector has a lot of growth opportunity, especially in robotics and structural heart valves; but it seems like J&J MDD would rather continue to invest in a declining Spine market and focus on other ventures instead of meaningful innovation in most of its existing platforms.

Johnson & Johnson JLabs

2 weeks ago

Give the list of companies a look and it's easy to see where JNJ's priority is: Biotech. There's almost no device companies and very little companies with a blended device/biotech market.

I wish Gorski would just admit JNJ doesn't care about the medical device business and sell it off because the future is obviously in biotech.

Consumer Products

3 weeks ago

Millions of dollars would be saved and useless middle management would be kicked to the curb with this plan!

Verb Surgical with JNJ and Google

3 weeks ago

All the silence about what is being developed makes me think they could be working on multiple robotic projects, including something in Spine. If there is anyone at NASS this week, there could be hints at the booth or in presentations. Report back!

J&J Acquisition Targets

4 weeks ago

A few things:

If you read the article, it was suggesting those two device makers as targets due to the shrinking device revenue in JnJ. I agree with your overall comment that a Biotech/Pharma company could potentially be more lucrative, but that wasn't what the author was trying to say. The point of the article was how to infuse device $. If you feel JnJ shouldnt invest in devices thats a fair position to have after Synthes and some of the other recent failures.

Edwards is on pace to do about 4bi…


1 month ago

Welcome to JNJ where they jack up the goals so much that no one can make incentive comp.

Jabril Strategic Collaboration

1 month ago

How about get rid of Consumer, saving millions for the company by firing Consumer management and support.

Problem solved.


2 months ago

Dan Zelem getting what he deserved.

J&J Layoffs

2 months ago

There's been no layoffs in pharma as off August but historically they start falling at the end of the year. Any info to report?